347 related articles for article (PubMed ID: 17660031)
1. Hemodialysis membrane with a high-molecular-weight cutoff and cytokine levels in sepsis complicated by acute renal failure: a phase 1 randomized trial.
Haase M; Bellomo R; Baldwin I; Haase-Fielitz A; Fealy N; Davenport P; Morgera S; Goehl H; Storr M; Boyce N; Neumayer HH
Am J Kidney Dis; 2007 Aug; 50(2):296-304. PubMed ID: 17660031
[TBL] [Abstract][Full Text] [Related]
2. Reduction in beta2-microglobulin with super-flux versus high-flux dialysis membranes: results of a 6-week, randomized, double-blind, crossover trial.
Pellicano R; Polkinghorne KR; Kerr PG
Am J Kidney Dis; 2008 Jul; 52(1):93-101. PubMed ID: 18423807
[TBL] [Abstract][Full Text] [Related]
3. Tailoring high-cut-off membranes and feasible application in sepsis-associated acute renal failure: in vitro studies.
Mariano F; Fonsato V; Lanfranco G; Pohlmeier R; Ronco C; Triolo G; Camussi G; Tetta C; Passlick-Deetjen J
Nephrol Dial Transplant; 2005 Jun; 20(6):1116-26. PubMed ID: 15814541
[TBL] [Abstract][Full Text] [Related]
4. A pilot, randomized, double-blind, cross-over study of high cut-off versus high-flux dialysis membranes.
Lee D; Haase M; Haase-Fielitz A; Paizis K; Goehl H; Bellomo R
Blood Purif; 2009; 28(4):365-72. PubMed ID: 19729908
[TBL] [Abstract][Full Text] [Related]
5. Role of the kidney in plasma cytokine removal in sepsis syndrome: a pilot study.
Graziani G; Bordone G; Bellato V; Finazzi S; Angelini C; Badalamenti S;
J Nephrol; 2006; 19(2):176-82. PubMed ID: 16736416
[TBL] [Abstract][Full Text] [Related]
6. Acute effect of hemodialysis on serum levels of the proinflammatory cytokines.
Tarakçioğlu M; Erbağci AB; Usalan C; Deveci R; Kocabaş R
Mediators Inflamm; 2003 Feb; 12(1):15-9. PubMed ID: 12745544
[TBL] [Abstract][Full Text] [Related]
7. Randomized controlled pilot study of 2 weeks' treatment with high cutoff membrane for hemodialysis patients with elevated C-reactive protein.
Fiedler R; Neugebauer F; Ulrich C; Wienke A; Gromann C; Storr M; Böhler T; Seibert E; Girndt M
Artif Organs; 2012 Oct; 36(10):886-93. PubMed ID: 22845695
[TBL] [Abstract][Full Text] [Related]
8. The effect of on-line high-flux hemofiltration versus low-flux hemodialysis on mortality in chronic kidney failure: a small randomized controlled trial.
Santoro A; Mancini E; Bolzani R; Boggi R; Cagnoli L; Francioso A; Fusaroli M; Piazza V; Rapanà R; Strippoli GF
Am J Kidney Dis; 2008 Sep; 52(3):507-18. PubMed ID: 18617304
[TBL] [Abstract][Full Text] [Related]
9. Intermittent hemodialysis versus continuous renal replacement therapy for acute renal failure in the intensive care unit: an observational outcomes analysis.
Rauf AA; Long KH; Gajic O; Anderson SS; Swaminathan L; Albright RC
J Intensive Care Med; 2008; 23(3):195-203. PubMed ID: 18474503
[TBL] [Abstract][Full Text] [Related]
10. Acute effects of intermittent hemodialysis and sustained low-efficiency hemodialysis (SLED) on the pulmonary function of patients under mechanical ventilation.
Steinhorst RC; Vieira JM; Abdulkader RC
Ren Fail; 2007; 29(3):341-5. PubMed ID: 17497449
[TBL] [Abstract][Full Text] [Related]
11. Beta2-microglobulin removal and plasma albumin levels with high cut-off hemodialysis.
Haase M; Bellomo R; Baldwin I; Haase-Fielitz A; Fealy N; Morgera S; Goehl H; Storr M; Boyce N; Neumayer HH
Int J Artif Organs; 2007 May; 30(5):385-92. PubMed ID: 17551901
[TBL] [Abstract][Full Text] [Related]
12. Continuous veno-venous hemofiltration improves hemodynamics in septic shock with acute renal failure without modifying TNFalpha and IL6 plasma concentrations.
Klouche K; Cavadore P; Portales P; Clot J; Canaud B; Béraud JJ
J Nephrol; 2002; 15(2):150-7. PubMed ID: 12018631
[TBL] [Abstract][Full Text] [Related]
13. Increased binding of beta-2-microglobulin to blood cells in dialysis patients treated with high-flux dialyzers compared with low-flux membranes contributed to reduced beta-2-microglobulin concentrations. Results of a cross-over study.
Traut M; Haufe CC; Eismann U; Deppisch RM; Stein G; Wolf G
Blood Purif; 2007; 25(5-6):432-40. PubMed ID: 17957097
[TBL] [Abstract][Full Text] [Related]
14. Outcomes of acute renal failure patients requiring intermittent hemodialysis.
Ozturk S; Arpaci D; Yazici H; Taymez DG; Aysuna N; Yildiz A; Sever MS
Ren Fail; 2007; 29(8):991-6. PubMed ID: 18067046
[TBL] [Abstract][Full Text] [Related]
15. A new synthetic dialyzer with advanced permselectivity for enhanced low-molecular weight protein removal.
Krieter DH; Lemke HD; Wanner C
Artif Organs; 2008 Jul; 32(7):547-54. PubMed ID: 18638309
[TBL] [Abstract][Full Text] [Related]
16. Extended daily dialysis in acute renal failure: a new therapeutic approach.
Kumar N; Ahlawat RS
Iran J Kidney Dis; 2007 Oct; 1(2):63-72. PubMed ID: 19363279
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of pretransplant serum cytokine levels in renal transplant recipients.
Berber I; Yiğit B; Işitmangil G; Tellioğlu G; Ozgezer T; Gülle S; Türkmen F; Titiz I
Transplant Proc; 2008; 40(1):92-3. PubMed ID: 18261555
[TBL] [Abstract][Full Text] [Related]
18. The impact of standard high-flux polysulfone versus novel high-flux polysulfone dialysis membranes on inflammatory markers: a randomized, single-blinded, controlled clinical trial.
Kerr PG; Sutherland WH; de Jong S; Vaithalingham I; Williams SM; Walker RJ
Am J Kidney Dis; 2007 Apr; 49(4):533-9. PubMed ID: 17386321
[TBL] [Abstract][Full Text] [Related]
19. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
20. The effect of increasing dialysis dose in overweight hemodialysis patients on quality of life: a 6-week randomized crossover trial.
Wang W; Tonelli M; Hemmelgarn B; Gao S; Johnson JA; Taub K; Manns B;
Am J Kidney Dis; 2008 May; 51(5):796-803. PubMed ID: 18436090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
